Skip to content

Virtual Reality Therapy for Pain Management at the Emergency Department

Virtual Reality Therapy for Pain Management at the Emergency Department

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06089642
Acronym
VRxOPUS-2
Enrollment
124
Registered
2023-10-18
Start date
2023-12-01
Completion date
2025-04-01
Last updated
2024-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Acute

Keywords

Virtual reality therapy, Pain at rest, Emergency department

Brief summary

Rationale: Prescriptions of analgesics, especially opioids, have doubled in the Emergency department (ED) over the past decades in response to frequently reported undertreatment of pain in ED patients. Consequently, there is a shift towards a more restrained utilisation of opioids at the ED. However, there are still few (non-)pharmacological alternatives. Virtual Reality (VR) therapy is a relatively new and promising technique in non-pharmacologic pain reduction and anxiolysis and shows positive results on pain relief and pain. Objective: Primary objective is to investigate the effect of VR on patient-reported pain outcomes in the ED. Secondary objectives are to investigate the effect of VR on analgesics use, patient-reported outcomes, and process indicators and to identify barriers to implementation. Last, subanalyses will be performed to compare the effectiveness of two types of VR: VR based on distraction (VRD) and VR based on focussed attention (VRF). Study design: randomized controlled trial. Study population: Adults admitted to the ED with a NRS pain score of 4 (out of ten) or more and unacceptable pain. Intervention: There will be a control group receiving usual care and a intervention group that receives additional VR therapy. Main study parameters/endpoints: The main study outcome is the difference in patient-reported NRS pain score.

Interventions

DEVICEVirtual reality

Virtual reality based on distraction and Virtual Reality based on focussed attention

Sponsors

Radboud University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Patient ≥16 years admitted to ED * NRS pain at rest score ≥4 * Pain not acceptable for patient * Patient is willing and able to comply with the study protoc

Exclusion criteria

* Patients initially treated by another physician than the emergency physician (EP). * EMV \< 14 * History of dementia, seizures * Severe hearing/visual impairment not corrected * Headwounds or damaged skin with which comfortable and hygienic use is not possible. * Presentation to the ED because of chronic pain (≥3 months) exacerbation * Chronic opioid use (≥3 months) * Psychiatric disorders interfering with patients' understanding of the study protocol and informed consent

Design outcomes

Primary

MeasureTime frameDescription
NRS-Pain score at restthroughout study participation, up to 8 hoursPain score before and after administration of VR

Secondary

MeasureTime frameDescription
Oral Morphine Equivalent (OME)throughout study participation, up to 8 hoursDose of morphines adminstered to a patient during their stay at the Emergency Department calculated in OME
Administered analgesics at the ED and typethroughout study participation, up to 8 hoursregistered type and total dose of analgesics administered to patient during the time they stayed at the Emergency Department
Administered non-pharmacological analgesia (e.g. casting, reduction of fracture)throughout study participation, up to 8 hoursregistered type of non-pharmacological analgesia adminstered during patients' stay at Emergency Department
Acceptability of pain at discharge (yes/no)Assessed at moment of discharge, up to 6 hours after inclusionAcceptability of pain at discharge (yes/no)
Patients desire for analgesics upon admittance and at discharge (yes/no)Asked at moment of admittance and at discharge, up to 6 hours after inclusionPatients desire for analgesics upon admittance and at discharge (yes/no)
NRS immersion scoreAssessed at moment of discharge, up to 6 hours after inclusionNumeric rating score to measure how immersed patients felt in the VR world
NRS anxiety scoresMeasured every 30 minutes until discharge of patient to maximal 6 hoursAnxiety score before and after administration of VR
Duration ED visitthroughout study participation, up to 8 hoursduration ED visit in hours
follow-up of patientAssessed at moment of discharge, up to 6 hours after inclusionregistered whether patient is admitted to hospital, discharged home or discharged to other facility
Analgesics prescription by emergency physicianthroughout study participation, up to 8 hourstype and dose of analgesics prescribed by emergency physician
Side effect during VR therapyevaluated every 30 minutes up to max 6 hoursOpen question
Interview one week after ED admission about patient experiencesapproximately one week after ED admissionInterview one week after ED admission about patient experiences exploring barriers and facilitators to implementation
Satisfaction with pain managementAssessed at moment of discharge, up to 6 hours after inclusionNumeric rating scale to score satisfaction of patients with pain management

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026